PhenoAge与PhenoAgeAccel在预测社区老年人躯体功能下降或死亡方面未优于实际年龄
基于InCHIANTI研究中979名≥65岁社区老年人的数据,分析了标准化实际年龄、表型年龄(PhenoAge)和表型年龄加速(PhenoAgeAccel)与躯体功能纵向变化及10年全因死亡的关系。三种指标均与功能下降和死亡显著相关,但实际年龄在预测rSPPB下降和死亡方面关联最强,PhenoAge和PhenoAgeAccel未表现出更优的预测价值。
要点
- 实际年龄与rSPPB下降(β=-0.41)和死亡(HR=2.78)的关联强于PhenoAge和PhenoAgeAccel。
- 实际年龄预测SPPB下降的AUC为0.71,优于PhenoAge的0.69和PhenoAgeAccel的0.55。
- 在社区老年人群中,PhenoAge和PhenoAgeAccel未优于实际年龄预测功能下降或死亡。
核心结论
- PhenoAge和PhenoAgeAccel虽与不良功能结局相关,但在一般老年人群中未优于实际年龄预测躯体功能下降或死亡。
研究设计与样本
- 基于InCHIANTI研究979名≥65岁社区老年人的数据,使用线性混合模型和Cox模型分析。
- 二次分析纳入504名基线躯体功能正常(SPPB≥10)的参与者,评估6年时功能受损(SPPB≤9)的预测价值。
主要发现
- 实际年龄与死亡的关联最强(HR=2.78),PhenoAge次之(HR=2.57),PhenoAgeAccel最弱(HR=1.71)。
- 预测SPPB下降的AUC:实际年龄0.71,PhenoAge 0.69,PhenoAgeAccel 0.55。
关键数值与推荐
- SPPB≥10定义为基线躯体功能正常,SPPB≤9定义为功能受损。
临床怎么用
- 在社区老年人群中,实际年龄仍是预测躯体功能下降和死亡的重要指标,PhenoAge和PhenoAgeAccel不宜替代实际年龄用于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronological age inadequately captures interindividual variability in aging-related functional decline. Biological age metrics such as PhenoAge and PhenoAgeAccel, based on clinical biomarkers, have shown associations with frailty and mortality in clinical populations, but their utility in predicting physical performance decline in community-dwelling older adults remains uncertain. METHODS: We used data from 979 participants aged ≥65 years in the InCHIANTI (Invecchiare in Chianti) study, with complete baseline biomarker and physical performance data. Associations of standardized (z-scores) chronological age, phenotypic age (PhenoAge), and Phenotypic Age Acceleration (PhenoAgeAccel) with longitudinal changes in physical function (rescaled SPPB [rSPPB], continuous rescaled Short Physical Performance Battery) and 10-year all-cause mortality were analyzed using linear mixed and Cox models, respectively. A secondary analysis in 504 participants with normal baseline physical performance (Short Physical Performance Battery [SPPB] ≥ 10) assessed the predictive value of each rescaled metric for the onset of compromised function (SPPB ≤ 9) at 6 years. Model performance was evaluated using Akaike information criterion (AIC) and area under the receiver operating characteristic curve (AUC). RESULTS: All 3 metrics showed statistically significant positive associations with physical function decline and mortality. Chronological age showed the strongest associations with rSPPB decline (β = -0.41, AIC = 3793) and mortality (hazard ratio [HR] = 2.78). PhenoAge (β = -0. 32, AIC = 4338, HR = 2.57) and PhenoAgeAccel (β = -0.14, AIC = 4642, HR = 1.71) showed weaker effects. Chronological age also outperformed PhenoAge and PhenoAgeAccel in predicting SPPB decline (AUC = 0.71 vs 0.69 and 0.55, respectively). CONCLUSION: While PhenoAge and PhenoAgeAccel are associated with adverse functional outcomes, they do not outperform chronological age in a general older population.
引用
- Iuorio MS, De Vincentis A, Lelli D, et al. PhenoAge and PhenoAgeAccel do not outperform chronological age in predicting physical performance decline or mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41454958. doi:10.1093/gerona/glaf285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。